期刊文献+

抗人卵巢癌单链抗体基因的构建 被引量:4

THE CONSTRUCTION OF SINGLE CHAIN Fv GENE OF ANTI-HUMAN OVARIAN CARCINOMA McAb
暂未订购
导出
摘要 目的构建抗人卵巢癌单抗COC183-B2单链抗体(scFv)基因。方法将通过PCR方法体外扩增并经测序验证的重链、轻链可变区(VH、VL)基因先后重组入原核表达质粒pTHA90相应的位点上,中间通过一连接肽(Gly4Ser)3基因连接构建成单链抗体基因(scFv),连接产物转化相应受体菌TOP10,提取质粒,酶切鉴定重组克隆。表达产物经ELISA方法测定活性。结果重组克隆经酶切鉴定可见预期大小的片段,表明重组成功。表达产物经ELISA检测证实具有与卵巢癌抗原结合的能力。结论本研究成功地构建了scFv基因。 Objective To construct single chain Fv (scFv) gene of anti-human ovarian carcinoma monoclonal antibody (McAb) COC183-B 2. Methods The heavy and light chain variable region genes of the antibody COC183-B 2 were inserted into two corresponding sites of expression vector pTHA90,and a scFv gene was constructed with a short peptide (Gly 4Ser) 3 gene. The recombinants were determined by digesting with Xho Ⅰ/Spe Ⅰ,Xba Ⅰ/EcoR Ⅰ and Xho Ⅰ/EcoR Ⅰ,and then were introduced into E.coli TOP 10 .The antigen binding activity of expressed product was detected with ELISA. Results The recombinants were determined by digesting with endonucleases and expected bands were identified. The value of expressed scFv was 3 times more than negative control by ELISA. Conclusion The scFv gene of COC183-B 2 was successfully constructed and expressed, and the expressed scFv fragment could interact specifically with ovarian carcinoma associated antigen.
出处 《徐州医学院学报》 CAS 1998年第6期446-448,共3页 Acta Academiae Medicinae Xuzhou
基金 国家自然科学基金
关键词 卵巢肿瘤 单链抗体 载体构建 基因表达 Ovarian carcinoma single-chain Fv Construction Expression
  • 相关文献

参考文献8

  • 1Bird RE, Hardman KD, Jocobson JW, et al. Single-chain antigen binding proteins. Science, 1988,242:423.
  • 2George AJT, Jamar F, Tai MS, et al. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: Technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peotide Proc Natl Acad Sci USA ,1995,92(18):8358.
  • 3Chaudhary VK. Batra Jk, Gallo MG, et al. A rapid method of cloning functional variable-region antibody genes in Escherichia coil as single-chain immunotoxins. Proc Natl.Acad Sci USA. 1990, 87(3):1066.
  • 4周萍,冯捷,蒋欣,黄华梁.抗人卵巢癌单克隆抗体COC183-B_2重链可变区基因的体外扩增、克隆及序列分析[J].北京医科大学学报,1998,30(3):202-204. 被引量:6
  • 5周萍,冯捷,钱和年,蒋欣,黄华梁.抗人卵巢癌单克隆抗体COC183-B_2轻链可变区基因的体外扩增、克隆及序列分析[J].徐州医学院学报,1998,18(3):173-175. 被引量:2
  • 6Huston JS, Levinson D, Mudgett-Hunter M, et al. Protein engineering of antibody binding sitc:Recovery of specific activiry in an anti-digoxin single-chain analog produced in E. coli.Proc Natl Acad Sci USA, 1988:85(16):5879.
  • 7Alfthan K, Takkinen K, Sizmann D, et al. Properties of a singlechain antibody containing different linker peptides. Protein Eng, 1995,8(7):725.
  • 8张香云,钱和年,邱并生,崔恒,冯捷,黄华梁,傅天云,李文锦,王建六,周萍,李小平.6B11卵巢癌抗独特型单链抗体表达及序列分析[J].北京医科大学学报,1996,28(4):252-255. 被引量:18

二级参考文献15

  • 1王勇,刘喜富,顾征,萧飒,陈艾,林晴,黄华梁,王登顺,李新元.抗人肺腺癌单克隆抗体重、轻链可变区基因的分离克隆和序列测定[J].Acta Genetica Sinica,1996,23(2):91-95. 被引量:7
  • 2钱和年,冯捷,崔恒,付天云,韦平,付志云,高博山,秦淑玲,高书明,杨宗宇.抗卵巢上皮癌单克隆抗体COC 183 B_2肿瘤免疫显像定位诊断的初步观察[J].北京医科大学学报,1990,22(5):327-330. 被引量:2
  • 3王建六,中华妇产科杂志,1996年,31卷,353页
  • 4钱和平,CMJ,1994年,107卷,99页
  • 5李成文,现代免疫化学技术,1992年
  • 6张香云,北京医科大学学报,1986年,28卷,92页
  • 7Qian H N,Gynecol Oncol,1992年,47卷,216页
  • 8James K,Bell GT,Human monoclonal antibody production,J Immunol Methods.1987.100(1):5.
  • 9Schroff RW.Foon KA,Beatty SM,et al,Humen anti-murine immunoglobulin responses in patients receiving monoclonal antibody cherapy.Cancer Res.1985.45(2):879.
  • 10Kabat EA.Wu TT.Perry HM,et al.Scquences of proteins of immunological interest.5th Edition.Bethesda M.D.U.S.Depart ment of Health and Human Services,Public Service.Nacional Institutes of Health.1991.

共引文献22

同被引文献31

  • 1林文玉,钱和年,冯捷,李文锦,高伯山,岳明纲,万里明,高书明.^(99m)Tc标单抗在荷人卵巢癌裸鼠体内T/N比值的观察[J].北京医科大学学报,1996,28(2):95-97. 被引量:2
  • 2刘喜富,萧飒,顾征,王勇,陈艾,林晴,张卫国,黄华梁,孙健,陈润生,沈倍奋,陈兴.抗人CD3单链抗体与改形单域抗体的表达[J].中国科学(C辑),1996,26(5):428-435. 被引量:7
  • 3杨渝珍 沈关心 周汝麟 主编.蛋白质的分离和分析技术[A].沈关心,周汝麟,主编.现代免疫学实验技术[C].武汉: 湖北科学技术出版社,2002.524~ 527.
  • 4Ying C, Laura L. Bispecific antibody conjugates in therapeutics.Advanced Drug Delivery Reviews, 2003, 55:171-197.
  • 5Marme A, Strauss G, Bastert G, et al. lntraperitoneal bispecific antibody (HEAI25×OKT3) therapy inhibits malignant ascites production in advanced ovarian carcinoma, Int J Cancer, 2002, 101:183-189.
  • 6Cochlovius B, Kipriyanov S M, Stassar M J, et al. Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3xCDI9 tandem diabody, and CD28 costimulation. Cancer Res, 2000, 60:4336--4341.
  • 7Gruber M, Schodin B A, Wilson E R, et al. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli. J Immunol, 1994, 17:5368-5374.
  • 8Holliger P, Prospero T, Winter CL 'Diabodies': small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA, 1993, 90:6444-6448.
  • 9Alt M, Muller R, Kontermann R E. Novel tetravalent and bispecific lgG-like antibody molecules combining single-chain diabodies with the immunoglobulin gammal Fc or CH3 region. FEBS Lett,1999, 454: 90-94.
  • 10Bargou R, Loftier A, Kufer P, et al. Clinical application of a recombinant bispecific single chain antibody CDI9xCD3 in patients with refractory B cell malignancies. Onkologie, 1999, 22:150.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部